Vitrolife AB (publ) (ADR)
General ticker "VTRLY" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $2.3B (TTM average)
Vitrolife AB (publ) (ADR) does not follow the US Stock Market performance with the rate: -17.7%.
Estimated limits based on current volatility of 0.0%: low 15.50$, high 15.50$
Factors to consider:
- Company pays dividends (annually): last record date 2025-05-02, amount 0.11$ (Y0.71%)
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [12.72$, 25.49$]
- 2025-12-31 to 2026-12-31 estimated range: [11.36$, 23.41$]
Financial Metrics affecting the VTRLY estimates:
- Positive: with PPE of 55.5 at the end of fiscal year the price was neutral
- Positive: Operating profit margin, % of 21.70 > 18.64
- Positive: Shareholder equity ratio, % of 78.18 > 63.39
- Positive: -4.48 < Investing cash flow per share per price, % of -1.29
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 2.86
- Positive: 0.33 < Operating cash flow per share per price, % of 3.10
- Positive: Industry inventory ratio change (median), % of -1.44 <= -0.15
- Positive: Interest expense per share per price, % of 0.34 <= 0.79
- Negative: Industry earnings per price (median), % of -3.67 <= 0
- Negative: Inventory ratio change, % of 1.15 > 0.84
- Negative: negative Industry operating cash flow (median)
Short-term VTRLY quotes
Long-term VTRLY plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | SEK3,234.00MM | SEK3,512.00MM | SEK3,609.00MM |
| Operating Expenses | SEK2,580.00MM | SEK7,101.00MM | SEK2,826.00MM |
| Operating Income | SEK654.00MM | SEK-3,589.00MM | SEK783.00MM |
| Non-Operating Income | SEK-117.00MM | SEK-123.00MM | SEK-109.00MM |
| Interest Expense | SEK44.00MM | SEK94.00MM | SEK98.00MM |
| R&D Expense | SEK143.00MM | SEK228.00MM | SEK117.00MM |
| Income(Loss) | SEK537.00MM | SEK-3,712.00MM | SEK674.00MM |
| Taxes | SEK0.00MM | SEK139.00MM | SEK160.00MM |
| Profit(Loss)* | SEK394.00MM | SEK-3,851.00MM | SEK513.00MM |
| Stockholders Equity | SEK16,736.00MM | SEK12,722.00MM | SEK13,639.00MM |
| Inventory | SEK405.00MM | SEK413.00MM | SEK422.00MM |
| Assets | SEK20,551.00MM | SEK16,329.00MM | SEK17,446.00MM |
| Operating Cash Flow | SEK636.00MM | SEK757.00MM | SEK907.00MM |
| Capital expenditure | SEK87.00MM | SEK119.00MM | SEK92.00MM |
| Investing Cash Flow | SEK-144.00MM | SEK-124.00MM | SEK-377.00MM |
| Financing Cash Flow | SEK-582.00MM | SEK-300.00MM | SEK-286.00MM |
| Earnings Per Share** | SEK2.91 | SEK-28.44 | SEK3.79 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.